CARDIOVASCULAR JOURNAL OF AFRICA • Volume 34, No 5, November/December 2023 316 AFRICA References 1. Gaye B, Diop M, Narayanan K, Offredo L, Reese P, Antignac M, et al. Epidemiological transition in morbidity: 10-year data from emergency consultations in Dakar, Senegal. Br Med J Glob Health 2019; 4(4): e001396. 2. GBD 2013 DALYs and HALE collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 2015; 386(10009): 2145–2191. 3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 populationbased measurement studies with 19.1 million participants. Lancet 2017; 389(10064): 37–55. 4. WorldHealthOrganization.AGlobal Brief onHypertension: SilentKiller, Global Public Health Crisis [Internet]. 2013 [cited 2020 Apr 16]. Available from: http://publichealthwell.ie/search-results/global-brief-hypertensionsilent-killer-global-public-health-crisis?source=relatedblock 5. Seeley A, Prynn J, Perera R, Street R, Davis D, Etyang AO. Pharmacotherapy for hypertension in Sub-Saharan Africa: a systematic review and network meta-analysis. BMC Med 2020; 18(1): 75. 6. Mancia G, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39(33): 3021–3104. 7. Mills KT, Obst KM, Shen W, Molina S, Zhang H-J, He H, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and metaanalysis. Ann Intern Med 2018; 168(2): 110–120. 8. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison HC, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNAGuideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71(6): e13–115. 9. Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review. BMC Med 2013; 11: 141. 10. Adigun AQ, Ishola DA, Akintomide AO, Ajayi AAL. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. J Hum Hypertens 2003; 17(4): 277–285. 11. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Br Med J 2015; 349(1): g7647. 12. World Bank Group – International Development, Poverty, & Sustainability [Internet]. [cited 2020 Apr 17]. Available from: https:// www.worldbank.org/ 13. Study Quality Assessment Tools. National Heart, Lung, and Blood Institute (NHLBI) [Internet]. [cited 2020 Apr 17]. Available from: https:// www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. 14. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg 2014; 12(12): 1500–1524. 15. Hesse IFA. Blood pressure response to out-patient drug treatment of hypertension in 1973–1993 at Korle-Bu Teaching Hospital, Accra, Ghana. West Afr J Med 2003; 22(2): 182–186. 16. Etuk E, Isezuo SA, Chika A, Akuche J, Ali M. Prescription pattern of anti-hypertensive drugs in a tertiary health institution in Nigeria. Ann Afr Med 2008; 7(3): 128–132. 17. Yusuff KB, Balogun OB. Pattern of drug utilization among hypertensives in a Nigerian teaching hospital. Pharmacoepidemiol Drug Saf 2005; 14(1): 69–74. 18. Yusuff KB, Balogun O. Physicians’ prescribing of anti-hypertensive combinations in a tertiary care setting in southwestern Nigeria. J Pharm Pharm Sci 2005; 8(2): 235–242. 19. Pillay T. A comparison of two methods for measuring anti-hypertensive drug use: concordance of use with South African standard treatment guidelines. Bull World Health Organ 2009; 87(6): 466–471. 20. Rayner B, Schoeman HS. A cross-sectional study of blood pressure control in hypertensive patients in general practice (the I-TARGET study). Cardiovasc J Afr 2009; 20(4): 224–227. 21. Olanrewaju TO, Aderibigbe A, Busari OA, Sanya EO. Antihypertensive drug utilization and conformity to guidelines in a Sub-Saharan African hypertensive population. Int J Clin Pharmacol Ther 2010; 48(1): 68–75. 22. Ganiyu K, Suleiman I. Assessment of antihypertensives utilization in a private teaching hospital in Nigeria. Int J Pharm Pharm Sci 2012; 4: 480–483. 23. Ilesanmi OS, Ige OK, Adebiyi AO. The managed hypertensive: the costs of blood pressure control in a Nigerian town. Pan Afr Med J 2012; 12: 96. 24. Konin C, Kramoh E, Anzouan-Kacou J-B, Essam N’Loo A, Yayé A, N’Djessan JJ, et al. Approche diagnostique et prise en charge de l’hypertension artérielle chez le personnel soignant du district d’Abidjan (Côte d’Ivoire). Rev DÉpidémiologie Santé Publique 2012; 60(1): 41–46. 25. Kramoh KE, Aké-Traboulsi E, Konin C, N’goran Y, Coulibaly I, Adoubi A, et al. Management of hypertension in the elderly patient at Abidjan Cardiology Institute (Ivory Coast). Int J Hypertens 2012; 2012: 1–6. 26. Omole MK, Oke GO. A ten year study of the pharmacotherapy of hypertension at a tertiary hospital in south western Nigeria. Asian J Pharm Clin Res 2012; 5(Suppl 1): 26–29. 27. Tamuno I, Babashani M. Blood pressure control amongst hypertensive patients in a tertiary health care facility in Northern Nigeria. Res J Med Sci 2012; 6(1): 26–32. 28. Ukwe CV, Ubaka CM. Antihypertensive drug prescribing in a tertiary hospital in eastern Nigeria. Trop J Pharm Res 2012; 11(2): 297–305. 29. Ojji DB, Ajayi SO, Mamven MH, Alfa J, Albertino D. Pattern of prescription of anti-hypertensive medications in a tertiary health care facility in Abuja, Nigeria. Ethn Dis 2013; 23(4): 480–483. 30. Shobana J, Semere M, Sied M, Eyob T, Russom M. Prescribing pattern of anti-hypertensive drugs among hypertension patients with cardiac complications in Eritrea. Lat Am J Pharm 2013; 32(5): 745–748. 31. Yaméogo NV, Kagambèga LJ, Millogo RCG, Kologo KJ, Yaméogo AA, Mandi GD, et al. Facteurs associés à un mauvais contrôle de la pression artérielle chez les hypertendus noirs africains: étude transversale de 456 hypertendus burkinabé. Ann Cardiol Angéiologie 2013; 62(1): 38–42. 32. Mutua EM, Gitonga MM, Mbuthia B, Muiruri N, Cheptum JJ, Maingi T. Level of blood pressure control among hypertensive patients on follow-up in a regional referral hospital in Central Kenya. Pan Afr Med J 2014; 18: 278. 33. Ikama MS, Nsitou BM, Makani J, Nkalla-Lambi M, Passi-Louamba C. Hypertension artérielle et niveau de contrôle à Brazzaville (Congo): place du Holter tensionnel. Ann Cardiol Angéiologie 2015; 64(2): 76–80. 34. Gabriel T, Shukrala F. Assessment of prescribing, dispensing, and patient use pattern of antihypertensive drugs for patients attending outpatient department of Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia. Drug Des Devel Ther 2015; 519.
RkJQdWJsaXNoZXIy NDIzNzc=